+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Clinical Microbiome Diagnostics Market Size, Share & Trends Analysis Report 2026-2033

  • PDF Icon

    Report

  • 120 Pages
  • September 2026
  • Region: Global
  • Grand View Research
  • ID: 6288545
The global clinical microbiome diagnostics market size was valued at USD 172.4 million in 2025 and is projected to grow from USD 195.7 million in 2026 to USD 500.8 million by 2033, at a CAGR of 14.4% from 2026 to 2033. North America dominated the market, accounting for the largest revenue share of 40.3% in 2025. Market growth is primarily driven by technological advancements in sequencing and bioinformatics, which are improving the accuracy, speed, and scalability of microbial profiling and data interpretation.

Global Clinical Microbiome Diagnostics Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For the purpose of this study, the analyst has segmented the global clinical microbiome diagnostics market report on the basis of product, technology, application, sample type, end use, and region:

Product Outlook (Revenue, USD Million, 2021 - 2033)

  • Diagnostic Tests & Assays
  • Diagnostic Testing Services
  • Diagnostic Software & Analysis

Technology Outlook (Revenue, USD Million, 2021 - 2033)

  • Sequencing-Based
  • PCR-Based
  • Mass Spectrometry-Based
  • Other Technologies

Application Outlook (Revenue, USD Million, 2021 - 2033)

  • Gastrointestinal Disorders
  • Infectious Diseases
  • Women's Health
  • Metabolic Disorders
  • Immune & Inflammatory Disorders
  • Neurological Disorders
  • Other Clinical Disorders

Sample Type Outlook (Revenue, USD Million, 2021 - 2033)

  • Gut
  • Oral
  • Vaginal
  • Skin
  • Respiratory
  • Other Sites

End use Outlook (Revenue, USD Million, 2021 - 2033)

  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Direct-to-Consumer

Regional Outlook (Revenue, USD Million, 2021 - 2033)

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Norway
  • Denmark
  • Sweden
  • Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
  • Latin America
  • Brazil
  • Argentina
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definitions
1.2.1. Product Segment
1.2.2. Technology Segment
1.2.3. Application Segment
1.2.4. Sample Type Segment
1.2.5. End use Segment
1.3. Information analysis
1.3.1. Market formulation & data visualization
1.4. Data validation & publishing
1.5. Information Procurement
1.5.1. Primary Infectious Disease Diagnostics
1.6. Information or Data Analysis
1.7. Market Formulation & Validation
1.8. Market Model
1.9. Total Market: CAGR Calculation
1.10. Objectives
1.10.1. Objective 1
1.10.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Insights Landscape
Chapter 3. Global Clinical Microbiome Diagnostics Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Growing prevalence of gastrointestinal and microbiome-associated disorders
3.2.1.2. Advancements in sequencing and molecular technologies
3.2.1.3. Increasing adoption of precision medicine
3.2.2. Market restraint analysis
3.2.2.1. Lack of standardization in testing methodologies
3.2.2.2. Limited clinical validation and utility
3.2.2.3. Complexity of microbiome data interpretation
3.2.3. Market opportunity analysis
3.3. Global Clinical Microbiome Diagnostics Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTLE Analysis
Chapter 4. Global Clinical Microbiome Diagnostics Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Global Clinical Microbiome Diagnostics Market Product Movement Analysis
4.3. Global Clinical Microbiome Diagnostics Market Size & Trend Analysis, Product, 2021 to 2033 (USD Million)
4.4. Diagnostic Tests & Assays
4.4.1. Diagnostic Tests & Assays market estimates and forecasts 2021 to 2033 (USD Million)
4.5. Diagnostic Testing Services
4.5.1. Diagnostic Testing Services market estimates and forecasts 2021 to 2033 (USD Million)
4.6. Diagnostic Software & Analysis
4.6.1. Diagnostic Software & Analysis market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 5. Global Clinical Microbiome Diagnostics Market: Technology Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Global Clinical Microbiome Diagnostics Market Technology Movement Analysis
5.2.1. Global Clinical Microbiome Diagnostics Market Size & Trend Analysis, Technology, 2021 to 2033 (USD Million)
5.3. Sequencing-Based
5.3.1. Sequencing-Based market estimates and forecasts 2021 to 2033 (USD Million)
5.4. PCR-BASED
5.4.1. PCR-BASED market estimates and forecasts 2021 to 2033 (USD Million)
5.5. Mass Spectrometry-Based
5.5.1. Mass Spectrometry-Based market estimates and forecasts 2021 to 2033 (USD Million)
5.6. Other Technologies
5.6.1. Other Technologies market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 6. Global Clinical Microbiome Diagnostics Market: Application Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Global Clinical Microbiome Diagnostics Market Application Movement Analysis
6.2.1. Global AI-enabled clinical laboratory analyzer Market Size & Trend Analysis, Application, 2021 to 2033 (USD Million)
6.3. Gastrointestinal Disorders
6.3.1. Gastrointestinal Disorders market estimates and forecasts 2021 to 2033 (USD Million)
6.4. Infectious Diseases
6.4.1. Infectious Diseases market estimates and forecasts 2021 to 2033 (USD Million)
6.5. Oncology
6.5.1. Oncology market estimates and forecasts 2021 to 2033 (USD Million)
6.6. Women’s Health
6.7. Women’s Health market estimates and forecasts 2021 to 2033 (USD Million)
6.8. Metabolic Disorders
6.8.1. Metabolic Disorders market estimates and forecasts 2021 to 2033 (USD Million)
6.9. Immune & Inflammatory Disorders
6.9.1. Immune & Inflammatory Disorders market estimates and forecasts 2021 to 2033 (USD Million)
6.10. Neurological Disorders
6.10.1. Neurological Disorders market estimates and forecasts 2021 to 2033 (USD Million)
6.11. Other Clinical Disorders
6.11.1. Other Clinical Disorders market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 7. Global Clinical Microbiome Diagnostics Market: Sample Type Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Global Clinical Microbiome Diagnostics Market Sample Type Movement Analysis
7.2.1. Global AI-enabled clinical laboratory analyzer Market Size & Trend Analysis, Sample Type, 2021 to 2033 (USD Million)
7.3. Gut
7.3.1. Gut market estimates and forecasts 2021 to 2033 (USD Million)
7.4. Oral
7.4.1. Oral market estimates and forecasts 2021 to 2033 (USD Million)
7.5. Vaginal
7.5.1. Vaginal market estimates and forecasts 2021 to 2033 (USD Million)
7.6. Skin
7.7. Skin market estimates and forecasts 2021 to 2033 (USD Million)
7.8. Respiratory
7.8.1. Respiratory market estimates and forecasts 2021 to 2033 (USD Million)
7.9. Other Sites
7.9.1. Other Sites market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 8. Global Clinical Microbiome Diagnostics Market: End use Estimates & Trend Analysis
8.1. Segment Dashboard
8.2. Global Clinical Microbiome Diagnostics Market End use Movement Analysis
8.2.1. Global AI-enabled clinical laboratory analyzer Market Size & Trend Analysis, End use, 2021 to 2033 (USD Million)
8.3. Hospitals & Clinics
8.3.1. Hospitals & Clinics market estimates and forecasts 2021 to 2033 (USD Million)
8.4. Diagnostic Laboratories
8.4.1. Diagnostic Laboratories market estimates and forecasts 2021 to 2033 (USD Million)
8.5. Direct-to-Consumer
8.5.1. Direct-to-Consumer market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 9. Clinical Microbiome Diagnostics Market: Regional Estimates & Trend Analysis
9.1. Regional Dashboard
9.2. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
9.3. North America
9.3.1. U.S.
9.3.1.1. Key country dynamics
9.3.1.2. Regulatory framework/ reimbursement structure
9.3.1.3. Competitive scenario
9.3.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
9.3.2. Canada
9.3.2.1. Key country dynamics
9.3.2.2. Regulatory framework/ reimbursement structure
9.3.2.3. Competitive scenario
9.3.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
9.3.3. Mexico
9.3.3.1. Key country dynamics
9.3.3.2. Regulatory framework/ reimbursement structure
9.3.3.3. Competitive scenario
9.3.3.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
9.4. Europe
9.4.1. UK
9.4.1.1. Key country dynamics
9.4.1.2. Regulatory framework/ reimbursement structure
9.4.1.3. Competitive scenario
9.4.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
9.4.2. Germany
9.4.2.1. Key country dynamics
9.4.2.2. Regulatory framework/ reimbursement structure
9.4.2.3. Competitive scenario
9.4.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
9.4.3. France
9.4.3.1. Key country dynamics
9.4.3.2. Regulatory framework/ reimbursement structure
9.4.3.3. Competitive scenario
9.4.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
9.4.4. Italy
9.4.4.1. Key country dynamics
9.4.4.2. Regulatory framework/ reimbursement structure
9.4.4.3. Competitive scenario
9.4.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
9.4.5. Spain
9.4.5.1. Key country dynamics
9.4.5.2. Regulatory framework/ reimbursement structure
9.4.5.3. Competitive scenario
9.4.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
9.4.6. Norway
9.4.6.1. Key country dynamics
9.4.6.2. Regulatory framework/ reimbursement structure
9.4.6.3. Competitive scenario
9.4.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
9.4.7. Sweden
9.4.7.1. Key country dynamics
9.4.7.2. Regulatory framework/ reimbursement structure
9.4.7.3. Competitive scenario
9.4.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
9.4.8. Denmark
9.4.8.1. Key country dynamics
9.4.8.2. Regulatory framework/ reimbursement structure
9.4.8.3. Competitive scenario
9.4.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
9.5. Asia Pacific
9.5.1. Japan
9.5.1.1. Key country dynamics
9.5.1.2. Regulatory framework/ reimbursement structure
9.5.1.3. Competitive scenario
9.5.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
9.5.2. China
9.5.2.1. Key country dynamics
9.5.2.2. Regulatory framework/ reimbursement structure
9.5.2.3. Competitive scenario
9.5.2.4. China market estimates and forecasts 2021 to 2033 (USD Million)
9.5.3. India
9.5.3.1. Key country dynamics
9.5.3.2. Regulatory framework/ reimbursement structure
9.5.3.3. Competitive scenario
9.5.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
9.5.4. Australia
9.5.4.1. Key country dynamics
9.5.4.2. Regulatory framework/ reimbursement structure
9.5.4.3. Competitive scenario
9.5.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
9.5.5. South Korea
9.5.5.1. Key country dynamics
9.5.5.2. Regulatory framework/ reimbursement structure
9.5.5.3. Competitive scenario
9.5.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
9.5.6. Thailand
9.5.6.1. Key country dynamics
9.5.6.2. Regulatory framework/ reimbursement structure
9.5.6.3. Competitive scenario
9.5.6.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
9.6. Latin America
9.6.1. Brazil
9.6.1.1. Key country dynamics
9.6.1.2. Regulatory framework/ reimbursement structure
9.6.1.3. Competitive scenario
9.6.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
9.6.2. Argentina
9.6.2.1. Key country dynamics
9.6.2.2. Regulatory framework/ reimbursement structure
9.6.2.3. Competitive scenario
9.6.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
9.7. MEA
9.7.1. South Africa
9.7.1.1. Key country dynamics
9.7.1.2. Regulatory framework/ reimbursement structure
9.7.1.3. Competitive scenario
9.7.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
9.7.2. Saudi Arabia
9.7.2.1. Key country dynamics
9.7.2.2. Regulatory framework/ reimbursement structure
9.7.2.3. Competitive scenario
9.7.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
9.7.3. UAE
9.7.3.1. Key country dynamics
9.7.3.2. Regulatory framework/ reimbursement structure
9.7.3.3. Competitive scenario
9.7.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
9.7.4. Kuwait
9.7.4.1. Key country dynamics
9.7.4.2. Regulatory framework/ reimbursement structure
9.7.4.3. Competitive scenario
9.7.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 10. Competitive Landscape
10.1. Company/Competition Categorization
10.2. Strategy Mapping
10.3. Company Market Share Analysis, 2025
10.4. List of Key Certification Providers/Scheme Owners
10.5. Company Profiles/Listing
10.5.1. Microba Life Sciences
10.5.1.1. Company overview
10.5.1.2. Financial performance
10.5.1.3. Product benchmarking
10.5.1.4. Strategic initiatives
10.5.2. Genetic Analysis AS
10.5.2.1. Company overview
10.5.2.2. Financial performance
10.5.2.3. Product benchmarking
10.5.2.4. Strategic initiatives
10.5.3. Genova Diagnostics
10.5.3.1. Company overview
10.5.3.2. Financial performance
10.5.3.3. Product benchmarking
10.5.3.4. Strategic initiatives
10.5.4. Viome
10.5.4.1. Company overview
10.5.4.2. Financial performance
10.5.4.3. Product benchmarking
10.5.4.4. Strategic initiatives
10.5.5. Evvy
10.5.5.1. Company overview
10.5.5.2. Financial performance
10.5.5.3. Product benchmarking
10.5.5.4. Strategic initiatives
10.5.6. Tiny Health
10.5.6.1. Company overview
10.5.6.2. Financial performance
10.5.6.3. Product benchmarking
10.5.6.4. Strategic initiatives
10.5.7. Jona Health
10.5.7.1. Company overview
10.5.7.2. Financial performance
10.5.7.3. Product benchmarking
10.5.7.4. Strategic initiatives
10.5.8. Sun Genomics
10.5.8.1. Company overview
10.5.8.2. Financial performance
10.5.8.3. Product benchmarking
10.5.8.4. Strategic initiatives
10.5.9. BIOHM Health
10.5.9.1. Company overview
10.5.9.2. Financial performance
10.5.9.3. Product benchmarking
10.5.9.4. Strategic initiatives
10.5.10. GoodGut
10.5.10.1. Company overview
10.5.10.2. Financial performance
10.5.10.3. Product benchmarking
10.5.10.4. Strategic initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviation
Table 3 Global Clinical Microbiome Diagnostics Market, Product, 2021 - 2033 (USD Million)
Table 4 Global Clinical Microbiome Diagnostics Market, technology, 2021 - 2033 (USD Million)
Table 5 Global Clinical Microbiome Diagnostics Market, application, 2021 - 2033 (USD Million)
Table 6 Global Clinical Microbiome Diagnostics Market, sample type, 2021 - 2033 (USD Million)
Table 7 Global Clinical Microbiome Diagnostics Market, end user Market, 2021 - 2033 (USD Million)
Table 8 North America Clinical Microbiome Diagnostics Market, Product, 2021 - 2033 (USD Million)
Table 9 North America Clinical Microbiome Diagnostics Market, technology, 2021 - 2033 (USD Million)
Table 10 North America Clinical Microbiome Diagnostics Market, application, 2021 - 2033 (USD Million)
Table 11 North America Clinical Microbiome Diagnostics Market, sample type, 2021 - 2033 (USD Million)
Table 12 North America Clinical Microbiome Diagnostics Market, end user Market, 2021 - 2033 (USD Million)
Table 13 U.S. Clinical Microbiome Diagnostics Market, Product, 2021 - 2033 (USD Million)
Table 14 U.S. Clinical Microbiome Diagnostics Market, technology, 2021 - 2033 (USD Million)
Table 15 U.S. Clinical Microbiome Diagnostics Market, application,2021 - 2033 (USD Million)
Table 16 U.S. Clinical Microbiome Diagnostics Market, sample type,2021 - 2033 (USD Million)
Table 17 U.S. Clinical Microbiome Diagnostics Market, end use, 2021 - 2033 (USD Million)
Table 18 Canada Clinical Microbiome Diagnostics Market, Product, 2021 - 2033 (USD Million)
Table 19 Canada Clinical Microbiome Diagnostics Market, technology, 2021 - 2033 (USD Million)
Table 20 Canada Clinical Microbiome Diagnostics Market, application, 2021 - 2033 (USD Million)
Table 21 Canada Clinical Microbiome Diagnostics Market, sample type, 2021 - 2033 (USD Million)
Table 22 Canada Clinical Microbiome Diagnostics Market, end use, 2021 - 2033 (USD Million)
Table 23 Mexico Clinical Microbiome Diagnostics Market, Product, 2021 - 2033 (USD Million)
Table 24 Mexico Clinical Microbiome Diagnostics Market, technology, 2021 - 2033 (USD Million)
Table 25 Mexico Clinical Microbiome Diagnostics Market, application, 2021 - 2033 (USD Million)
Table 26 Mexico Clinical Microbiome Diagnostics Market, sample type, 2021 - 2033 (USD Million)
Table 27 Mexico Clinical Microbiome Diagnostics Market, end use, 2021 - 2033 (USD Million)
Table 28 Europe Clinical Microbiome Diagnostics Market, region, 2021 - 2033 (USD Million)
Table 29 Europe Clinical Microbiome Diagnostics Market, Product, 2021 - 2033 (USD Million)
Table 30 Europe Clinical Microbiome Diagnostics Market, technology, 2021 - 2033 (USD Million)
Table 31 Europe Clinical Microbiome Diagnostics Market, application, 2021 - 2033 (USD Million)
Table 32 Europe Clinical Microbiome Diagnostics Market, sample type, 2021 - 2033 (USD Million)
Table 33 Europe Clinical Microbiome Diagnostics Market, end use, 2021 - 2033 (USD Million)
Table 34 UK Clinical Microbiome Diagnostics Market, Product, 2021 - 2033 (USD Million)
Table 35 UK Clinical Microbiome Diagnostics Market, technology, 2021 - 2033 (USD Million)
Table 36 UK Clinical Microbiome Diagnostics Market, application, 2021 - 2033 (USD Million)
Table 37 UK Clinical Microbiome Diagnostics Market, sample type, 2021 - 2033 (USD Million)
Table 38 UK Clinical Microbiome Diagnostics Market, end use, 2021 - 2033 (USD Million)
Table 39 Germany Clinical Microbiome Diagnostics Market, Product, 2021 - 2033 (USD Million)
Table 40 Germany Clinical Microbiome Diagnostics Market, technology, 2021 - 2033 (USD Million)
Table 41 Germany Clinical Microbiome Diagnostics Market, application, 2021 - 2033 (USD Million)
Table 42 Germany Clinical Microbiome Diagnostics Market, sample type, 2021 - 2033 (USD Million)
Table 43 Germany Clinical Microbiome Diagnostics Market, end use, 2021 - 2033 (USD Million)
Table 44 France Clinical Microbiome Diagnostics Market, Product, 2021 - 2033 (USD Million)
Table 45 France Clinical Microbiome Diagnostics Market, technology, 2021 - 2033 (USD Million)
Table 46 France Clinical Microbiome Diagnostics Market, application, 2021 - 2033 (USD Million)
Table 47 France Clinical Microbiome Diagnostics Market, sample type, 2021 - 2033 (USD Million)
Table 48 France Clinical Microbiome Diagnostics Market, end use, 2021 - 2033 (USD Million)
Table 49 Italy Clinical Microbiome Diagnostics Market, Product, 2021 - 2033 (USD Million)
Table 50 Italy Clinical Microbiome Diagnostics Market, technology, 2021 - 2033 (USD Million)
Table 51 Italy Clinical Microbiome Diagnostics Market, application, 2021 - 2033 (USD Million)
Table 52 Italy Clinical Microbiome Diagnostics Market, sample type, 2021 - 2033 (USD Million)
Table 53 Italy Clinical Microbiome Diagnostics Market, end use, 2021 - 2033 (USD Million)
Table 54 Spain Clinical Microbiome Diagnostics Market, Product, 2021 - 2033 (USD Million)
Table 55 Spain Clinical Microbiome Diagnostics Market, technology, 2021 - 2033 (USD Million)
Table 56 Spain Clinical Microbiome Diagnostics Market, application, 2021 - 2033 (USD Million)
Table 57 Spain Clinical Microbiome Diagnostics Market, sample type, 2021 - 2033 (USD Million)
Table 58 Spain Clinical Microbiome Diagnostics Market, end use, 2021 - 2033 (USD Million)
Table 59 Denmark Clinical Microbiome Diagnostics Market, Product, 2021 - 2033 (USD Million)
Table 60 Denmark Clinical Microbiome Diagnostics Market, technology, 2021 - 2033 (USD Million)
Table 61 Denmark Clinical Microbiome Diagnostics Market, application, 2021 - 2033 (USD Million)
Table 62 Denmark Clinical Microbiome Diagnostics Market, sample type, 2021 - 2033 (USD Million)
Table 63 Denmark Clinical Microbiome Diagnostics Market, end use, 2021 - 2033 (USD Million)
Table 64 Sweden Clinical Microbiome Diagnostics Market, Product, 2021 - 2033 (USD Million)
Table 65 Sweden Clinical Microbiome Diagnostics Market, technology, 2021 - 2033 (USD Million)
Table 66 Sweden Clinical Microbiome Diagnostics Market, application, 2021 - 2033 (USD Million)
Table 67 Sweden Clinical Microbiome Diagnostics Market, sample type, 2021 - 2033 (USD Million)
Table 68 Sweden Clinical Microbiome Diagnostics Market, end use, 2021 - 2033 (USD Million)
Table 69 Norway Clinical Microbiome Diagnostics Market, Product, 2021 - 2033 (USD Million)
Table 70 Norway Clinical Microbiome Diagnostics Market, technology, 2021 - 2033 (USD Million)
Table 71 Norway Clinical Microbiome Diagnostics Market, application, 2021 - 2033 (USD Million)
Table 72 Norway Clinical Microbiome Diagnostics Market, sample type, 2021 - 2033 (USD Million)
Table 73 Norway Clinical Microbiome Diagnostics Market, end use, 2021 - 2033 (USD Million)
Table 74 Asia Pacific Clinical Microbiome Diagnostics Market, region, 2021 - 2033 (USD Million)
Table 75 Asia Pacific Clinical Microbiome Diagnostics Market, Product, 2021 - 2033 (USD Million)
Table 76 Asia Pacific Clinical Microbiome Diagnostics Market, technology, 2021 - 2033 (USD Million)
Table 77 Asia Pacific Clinical Microbiome Diagnostics Market, application, 2021 - 2033 (USD Million)
Table 78 Asia Pacific Clinical Microbiome Diagnostics Market, sample type, 2021 - 2033 (USD Million)
Table 79 Asia Pacific Clinical Microbiome Diagnostics Market, end use, 2021 - 2033 (USD Million)
Table 80 Japan Clinical Microbiome Diagnostics Market, Product, 2021 - 2033 (USD Million)
Table 81 Japan Clinical Microbiome Diagnostics Market, technology, 2021 - 2033 (USD Million)
Table 82 Japan Clinical Microbiome Diagnostics Market, application, 2021 - 2033 (USD Million)
Table 83 Japan Clinical Microbiome Diagnostics Market, sample type, 2021 - 2033 (USD Million)
Table 84 Japan Clinical Microbiome Diagnostics Market, end use, 2021 - 2033 (USD Million)
Table 85 China Clinical Microbiome Diagnostics Market, Product, 2021 - 2033 (USD Million)
Table 86 China Clinical Microbiome Diagnostics Market, technology, 2021 - 2033 (USD Million)
Table 87 China Clinical Microbiome Diagnostics Market, application, 2021 - 2033 (USD Million)
Table 88 China Clinical Microbiome Diagnostics Market, sample type, 2021 - 2033 (USD Million)
Table 89 China Clinical Microbiome Diagnostics Market, end use, 2021 - 2033 (USD Million)
Table 90 India Clinical Microbiome Diagnostics Market, Product, 2021 - 2033 (USD Million)
Table 91 India Clinical Microbiome Diagnostics Market, technology, 2021 - 2033 (USD Million)
Table 92 India Clinical Microbiome Diagnostics Market, application, 2021 - 2033 (USD Million)
Table 93 India Clinical Microbiome Diagnostics Market, sample type, 2021 - 2033 (USD Million)
Table 94 India Clinical Microbiome Diagnostics Market, end use, 2021 - 2033 (USD Million)
Table 95 Australia Clinical Microbiome Diagnostics Market, Product, 2021 - 2033 (USD Million)
Table 96 Australia Clinical Microbiome Diagnostics Market, technology, 2021 - 2033 (USD Million)
Table 97 Australia Clinical Microbiome Diagnostics Market, application, 2021 - 2033 (USD Million)
Table 98 Australia Clinical Microbiome Diagnostics Market, sample type, 2021 - 2033 (USD Million)
Table 99 Australia Clinical Microbiome Diagnostics Market, end use, 2021 - 2033 (USD Million)
Table 100 South Korea Clinical Microbiome Diagnostics Market, Product, 2021 - 2033 (USD Million)
Table 101 South Korea Clinical Microbiome Diagnostics Market, technology, 2021 - 2033 (USD Million)
Table 102 South Korea Clinical Microbiome Diagnostics Market, application, 2021 - 2033 (USD Million)
Table 103 South Korea Clinical Microbiome Diagnostics Market, sample type, 2021 - 2033 (USD Million)
Table 104 South Korea Clinical Microbiome Diagnostics Market, end use, 2021 - 2033 (USD Million)
Table 105 Thailand Clinical Microbiome Diagnostics Market, Product, 2021 - 2033 (USD Million)
Table 106 Thailand Clinical Microbiome Diagnostics Market, technology, 2021 - 2033 (USD Million)
Table 107 Thailand Clinical Microbiome Diagnostics Market, application, 2021 - 2033 (USD Million)
Table 108 Thailand Clinical Microbiome Diagnostics Market, sample type, 2021 - 2033 (USD Million)
Table 109 Thailand Clinical Microbiome Diagnostics Market, end use, 2021 - 2033 (USD Million)
Table 110 Latin Clinical Microbiome Diagnostics Market, region, 2021 - 2033 (USD Million)
Table 111 Latin Clinical Microbiome Diagnostics Market, Product, 2021 - 2033 (USD Million)
Table 112 Latin Clinical Microbiome Diagnostics Market, technology, 2021 - 2033 (USD Million)
Table 113 Latin Clinical Microbiome Diagnostics Market, application, 2021 - 2033 (USD Million)
Table 114 Latin Clinical Microbiome Diagnostics Market, sample type, 2021 - 2033 (USD Million)
Table 115 Latin Clinical Microbiome Diagnostics Market, end use, 2021 - 2033 (USD Million)
Table 116 Brazil Clinical Microbiome Diagnostics Market, Product, 2021 - 2033 (USD Million)
Table 117 Brazil Clinical Microbiome Diagnostics Market, technology, 2021 - 2033 (USD Million)
Table 118 Brazil Clinical Microbiome Diagnostics Market, application, 2021 - 2033 (USD Million)
Table 119 Brazil Clinical Microbiome Diagnostics Market, sample type, 2021 - 2033 (USD Million)
Table 120 Brazil Clinical Microbiome Diagnostics Market, end use, 2021 - 2033 (USD Million)
Table 121 Argentina Clinical Microbiome Diagnostics Market, Product, 2021 - 2033 (USD Million)
Table 122 Argentina Clinical Microbiome Diagnostics Market, technology, 2021 - 2033 (USD Million)
Table 123 Argentina Clinical Microbiome Diagnostics Market, application, 2021 - 2033 (USD Million)
Table 124 Argentina Clinical Microbiome Diagnostics Market, sample type, 2021 - 2033 (USD Million)
Table 125 Argentina Clinical Microbiome Diagnostics Market, end use, 2021 - 2033 (USD Million)
Table 126 MEA Clinical Microbiome Diagnostics Market, region, 2021 - 2033 (USD Million)
Table 127 MEA Clinical Microbiome Diagnostics Market, Product, 2021 - 2033 (USD Million)
Table 128 MEA Clinical Microbiome Diagnostics Market, technology, 2021 - 2033 (USD Million)
Table 129 MEA Clinical Microbiome Diagnostics Market, application, 2021 - 2033 (USD Million)
Table 130 MEA Clinical Microbiome Diagnostics Market, sample type, 2021 - 2033 (USD Million)
Table 131 MEA Clinical Microbiome Diagnostics Market, end use, 2021 - 2033 (USD Million)
Table 132 South Africa Clinical Microbiome Diagnostics Market, Product, 2021 - 2033 (USD Million)
Table 133 South Africa Clinical Microbiome Diagnostics Market, technology, 2021 - 2033 (USD Million)
Table 134 South Africa Clinical Microbiome Diagnostics Market, application, 2021 - 2033 (USD Million)
Table 135 South Africa Clinical Microbiome Diagnostics Market, sample type, 2021 - 2033 (USD Million)
Table 136 South Africa Clinical Microbiome Diagnostics Market, end use, 2021 - 2033 (USD Million)
Table 137 Saudi Arabia Clinical Microbiome Diagnostics Market, Product, 2021 - 2033 (USD Million)
Table 138 Saudi Arabia Clinical Microbiome Diagnostics Market, technology, 2021 - 2033 (USD Million)
Table 139 Saudi Arabia Clinical Microbiome Diagnostics Market, application, 2021 - 2033 (USD Million)
Table 140 Saudi Arabia Clinical Microbiome Diagnostics Market, sample type, 2021 - 2033 (USD Million)
Table 141 Saudi Arabia Clinical Microbiome Diagnostics Market, end use, 2021 - 2033 (USD Million)
Table 142 UAE Clinical Microbiome Diagnostics Market, Product, 2021 - 2033 (USD Million)
Table 143 UAE Clinical Microbiome Diagnostics Market, technology, 2021 - 2033 (USD Million)
Table 144 UAE Clinical Microbiome Diagnostics Market, application, 2021 - 2033 (USD Million)
Table 145 UAE Clinical Microbiome Diagnostics Market, sample type, 2021 - 2033 (USD Million)
Table 146 UAE Clinical Microbiome Diagnostics Market, end use, 2021 - 2033 (USD Million)
Table 147 Kuwait Clinical Microbiome Diagnostics Market, Product, 2021 - 2033 (USD Million)
Table 148 Kuwait Clinical Microbiome Diagnostics Market, technology, 2021 - 2033 (USD Million)
Table 149 Kuwait Clinical Microbiome Diagnostics Market, application, 2021 - 2033 (USD Million)
Table 150 Kuwait Clinical Microbiome Diagnostics Market, sample type, 2021 - 2033 (USD Million)
Table 151 Kuwait Clinical Microbiome Diagnostics Market, end use, 2021 - 2033 (USD Million)
List of Figures
Fig. 1 Market research process
Figure 2 Data triangulation techniques
Figure 3 Primary research pattern
Figure 4 Market research approaches
Figure 5 Value-chain-based sizing & forecasting
Figure 6 QFD modelling for market share assessment
Figure 7 Market formulation & validation
Figure 8 Clinical Microbiome Diagnostics Market: Market outlook
Figure 9 Clinical Microbiome Diagnostics Market: Competitive insights
Figure 10 Parent market outlook
Figure 11 Related/ancillary market outlook
Figure 12 Penetration and growth prospect mapping
Figure 13 Industry value chain analysis
Figure 14 Clinical Microbiome Diagnostics Market driver impact
Figure 15 Clinical Microbiome Diagnostics Market restraint impact
Figure 16 Clinical Microbiome Diagnostics Market strategic initiatives analysis
Figure 17 Clinical Microbiome Diagnostics Market: Product movement analysis
Figure 18 Clinical Microbiome Diagnostics Market: Product outlook and key takeaways
Figure 19 Diagnostic Tests & Assays market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 20 Diagnostic Testing Services market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 21 Diagnostic Software & Analysis market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 22 Clinical Microbiome Diagnostics Market: Technology movement analysis
Figure 23 Clinical Microbiome Diagnostics Market: Technology outlook and key takeaways
Figure 24 Sequencing-Based market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 25 PCR-BASED market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 26 Mass Spectrometry-Based market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 27 Other Technologies market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 28 Clinical Microbiome Diagnostics Market: Application movement analysis
Figure 29 Clinical Microbiome Diagnostics Market: Application outlook and key takeaways
Figure 30 Gastrointestinal Disorders market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 31 Infectious Diseases market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 32 Oncology market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 33 Women’s Health market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 34 Metabolic Disorders market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 35 Immune & Inflammatory Disorders market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 36 Neurological Disorders market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 37 Other Clinical Disorders market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 38 Clinical Microbiome Diagnostics Market: Sample type movement analysis
Figure 39 Clinical Microbiome Diagnostics Market: Sample type outlook and key takeaways
Figure 40 Gut market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 41 Oral market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 42 Vaginal market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 43 Skin market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 44 Respiratory market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 45 Other Sites market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 46 Clinical Microbiome Diagnostics Market: End use movement analysis
Figure 47 Clinical Microbiome Diagnostics Market: End use outlook and key takeaways
Figure 48 Hospitals & Clinics market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 49 Diagnostic Laboratories market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 50 Direct-to-Consumer market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 51 Specialty Diagnostic Centers market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 52 Global Clinical Microbiome Diagnostics Market: Regional movement analysis
Figure 53 Global Clinical Microbiome Diagnostics Market: Regional outlook and key takeaways
Figure 54 North America market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 55 U.S. market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 56 Canada market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 57 Mexico market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 58 Europe market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 59 UK market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 60 Germany market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 61 France market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 62 Italy market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 63 Spain market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 64 Sweden market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 65 Norway market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 66 Denmark market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 67 Asia Pacific market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 68 Japan market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 69 China market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 70 India market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 71 Australia market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 72 Thailand market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 73 South Korea market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 74 Latin America market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 75 Brazil market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 76 Argentina market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 77 Middle East and Africa. market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 78 Saudi Arabia market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 79 South Africa market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 80 UAE market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 81 Kuwait market estimates and forecasts, 2021 - 2033 (USD Million)

Companies Mentioned

  • Microba Life Sciences
  • Genetic Analysis AS
  • Genova Diagnostics
  • Viome
  • Evvy
  • Tiny Health
  • Jona Health
  • Sun Genomics
  • BIOHM Health
  • GoodGut